---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-005640"
form_type: "8-K"
ticker: "UG"
cik: "0000101295"
company_name: "UNITED GUARDIAN INC"
filed_at: "2022-08-12T23:59:59+00:00"
generated_at: "2026-06-24T00:12:00.200251+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# United-Guardian Q2 net income down 53% to $0.14/share; H1 sales up 6%

## Summary
- H1 2022 sales $7.52M (+6% YoY); net income $1.54M ($0.34/share) vs $2.53M ($0.55/share) in H1 2021.
- Q2 net income fell to $633K ($0.14/share) from $1.34M ($0.29/share); sales down slightly to $3.63M.
- Profit hit by higher raw material and shipping costs and decline in marketable securities value.
- Pharmaceutical product sales up 8% QoQ; non-pharmaceutical medical product sales surged 55% on China order.
- Company implemented price increases in April to partially offset rising costs; optimistic on securities recovery.

## SEC filing metadata
- accession: 0001171843-22-005640
- form_type: 8-K
- ticker: UG
- cik: 0000101295
- company_name: UNITED GUARDIAN INC
- filed_at: 2022-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/101295/000117184322005640/0001171843-22-005640-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/101295/000117184322005640/f8k_080122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-005640
- JSON: https://secwatch.observer/filing/0001171843-22-005640.json
- Plain text: https://secwatch.observer/filing/0001171843-22-005640.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.